SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of therapeutics for metabolic dysfunction-associated steatohepatitis. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.

Madrigal Pharmaceuticals Inc

Madrigals strong quarterly Rezdiffra growth and first profitable quarter were followed by a sharp share-price selloff, prompting traders to question why the stock fell despite the results. Bulls point to growing adoption and profitability, while skeptics focus on spending, reimbursement and the need for longer-term clinical outcomes evidence.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Record quarterly results and raised fiscal-year revenue guidance, supported by strong bookings and backlog tied to AI-chip testing demand, have driven AEHRs sharp rally. Bulls welcome the beat-and-raise and see further AI-driven growth, while skeptics question the valuation and warn the sharp gap-up could fade.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizers quarterly results beat expectations and the company raised its full-year outlook, drawing attention to its turnaround and cost-cutting efforts. Bulls point to growth in newer products, while skeptics cite flat overall revenue, declining COVID-related sales and looming patent expirations, questioning whether the progress is enough to sustain the rally.

Fiserv, Inc. engages in the provision of financial services technology. It operates through the Merchant and Financial segments. The Merchant segment offers commerce-enabling products and services including merchant acquiring and digital commerce and mobile payment services, and security and fraud protection, stored-value, and pay-by-bank solutions to companies of all sizes. The Financial segment provides products and services such as processing of customer loan and deposit accounts, digital payments, and card transactions to financial institutions and corporate and public sector clients. The company was founded by Leslie M. Muma and George D. Dalton on July 31, 1984 and is headquartered in Milwaukee, WI.

Fiserv, Inc.

Fiservs quarterly earnings beat, reaffirmed outlook, expanded cost-savings plan and planned share repurchases have fueled a sharp rebound after a prolonged slide. Bulls see signs of a turnaround under new leadership, while skeptics point to weak underlying growth and margin pressure as reasons to question whether the recovery can last.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

With Q3 results approaching, traders are focused on selling pressure ahead of the report, with some speculatingwithout confirmationthat weak results leaked or a large holder is reducing exposure. Others see the pullback as a shakeout and cite the 200-day moving-average reclaim and possible continued buybacks as reasons for optimism.

Backblaze, Inc. operates as a cloud provider for businesses and consumers to store, use, and protect their data. The firm provides a foundation for businesses, developers, IT professionals, and individuals to store, backup, and archive data, host content, manage media, and build their applications. It also offers B2 Cloud Storage and Computer Backup services. The company was founded by Timothy Nufire, Gleb Budman, Charles Jones, Kwok Hang Ng, Brian Wilson, Nilay Patel and Damon Uyeda in 2007 and is headquartered in San Francisco, CA.

Backblaze Inc - Ordinary Shares - Class A

Backblazes strong Q3 results and raised full-year outlook, led by accelerating B2 cloud-storage growth amid AI demand, are driving attention. Bulls view the results as evidence of an AI-storage growth opportunity, while skeptics point to the sharp post-earnings reversal and concerns about customer retention, free cash flow, and shrinking legacy backup.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is drawing attention ahead of its quarterly report, with traders focused on whether its outlookespecially for AI and data-center demandcan reassure investors after Intels weak forecast raised concerns about chip demand. Views are sharply divided: some expect strong results to support a rebound, while others worry that even a beat could be sold off if guidance disappoints or broader tech weakness persists.

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. The United States segment focuses on therapeutic area of central nervous system (CNS) portfolio, and is involved in the distribution business of generic, biosimilar and medicines, and over-the-counter (OTC) pharmaceutical products from the firm and third-party manufacturers to independent retail pharmacies, pharmacy retail chains, hospitals, and physician offices in the United States. The Europe segment offers OTC portfolio including SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brands in European Union, the United Kingdom, and certain other European countries. The International Markets segment provides its products to countries such as Canada, Israel, Russia, Latin America, and Japan. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Teva- Pharmaceutical Industries Ltd.

Teva- Pharmaceutical Industries Ltd. - ADR

Tevas Q3 earnings beat and higher full-year outlook are driving attention, with traders highlighting strong growth in AUSTEDO, AJOVY and UZEDY despite continued pressure on generics. The reaction is broadly bullish, though some note that generics weakness remains a drag on the growth story.

Shopify, Inc. is a global commerce company that provides essential internet infrastructure for commerce, offering trusted tools to start, scale, market, and run a retail business of any size. The Company's software enables merchants to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts and marketplaces. The Shopify platform provides merchants with a single view of their business across all of their sales channels and enables them to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics and reporting and access financing, all from one integrated back office. The company was founded on September 28, 2004 and is headquartered in Ottawa, Canada.

Shopify Inc - Ordinary Shares - Class A (Sub Voting)

Shopify Inc

Shopify is drawing attention after quarterly GMV and subscription results came in below expectations, prompting a sharp selloff despite an earnings beat and continued revenue growth. Traders are split between concerns about slowing growth and a high valuation and dip buyers who see the decline as an overreaction to otherwise solid results.

Keeta (KTA) is a cryptocurrency launched in 2025. Keeta has a current supply of 1,000,000,000 with 628,961,319.40126972 in circulation. The last known price of Keeta is 0.05762589 USD and is down -3.01 over the last 24 hours. It is currently trading on 112 active market(s) with $573,273.62 traded over the last 24 hours. More information can be found at https://keeta.com/.

Keeta

Keeta Personals rollout and its fiat-payment integrations, including ACH capabilities and Visa Direct/Bivo Cash, are driving attention, alongside broader plans for institutional payment and asset-tokenization rails. Bulls see the launches and partnerships as a path to adoption, while skeptics point to weak sustained usage and question whether network activity will create demand for KTA; unconfirmed bank and Google-partner speculation also circulates.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ORCL My $ORCX was as low as -10% in the premarket bottom, but after adding more to lower the avg, now it&#39;s up 3%.   Would love to ride this back up my $14.09 avg. to near $20 (again !!).

Diego Perez Bonano

Jesse Adamiak

StockTwits Web

Oracle Corp.

Defiance Daily Target 2X Long ORCL ETF

 was as low as -10% in the premarket bottom, but after adding more to lower the avg, now it's up 3%.   Would love to ride this back up my $14.09 avg. to near $20 (again !!).